DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Huguenard JR, McCormick DA. Thalamic synchrony and
dynamic regulation of global forebrain oscillations. Trends
Neurosci, 2007 30:350–356.
Kelly KM, Gross RA, Macdonald RL. Valproic acid selectively
reduces the low-threshold (T) calcium current in rat nodose
neurons. Neurosci Lett, 1990, 116:233–238.
Kwan P, Brodie MJ. Early identification of refractory epilepsy.
N Engl J Med, 2000, 342:314–319.
Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J
Med, 1998, 338:970–976.
Macdonald RL, Greenfield LJ Jr. Mechanisms of action of new
antiepileptic drugs. Curr Opin Neurol, 1997, 10:121–128.
Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine,
phenobarbital, phenytoin, and primidone in partial
and secondarily generalized tonic-clonic seizures. N Engl J
Med, 1985, 313:145–151.
Mattson RH, Cramer JA, Collins JF. A comparison of valproate
with carbamazepine for the treatment of complex partial
seizures and secondarily generalized tonic-clonic seizures in
adults. The Department of Veterans Affairs Epilepsy
Cooperative Study No. 264 Group. N Engl J Med, 1992,
327:765–771.
McLean MJ, Macdonald RL. Carbamazepine and 10,11-epoxycarbamazepine
produce use- and voltage-dependent limitation
of rapidly firing action potentials of mouse central neurons in
cell culture. J Pharmacol Exp Ther, 1986a, 238:727–738.
McLean MJ, Macdonald RL. Sodium valproate, but not ethosuximide,
produces use- and voltage-dependent limitation of highfrequency
repetitive firing of action potentials of mouse central
neurons in cell culture. J Pharmacol Exp Ther, 1986b,
237:1001–1011.
McNamara JO. Cellular and molecular basis of epilepsy. J Neurosci,
1994, 14:3413–3425.
Mikati MA, Browne TR. Comparative efficacy of antiepileptic
drugs. Clin Neuropharmacol, 1988, 11:130–140.
Miller NR, Johnson MA, Paul SR, et al. Visual dysfunction in
patients receiving vigabatrin: clinical and electrophysiologic
findings. Neurology, 1999, 53:2082–2087.
Morrell MJ. Guidelines for the care of women with epilepsy.
Neurology, 1998, 51:S21–S27.
Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized
seizures associated with the Lennox-Gastaut syndrome.
Lamictal Lennox-Gastaut Study Group. N Engl J Med,
1997, 337:1807–1812.
Pack AM. Therapy insight: Clinical management of pregnant
women with epilepsy. Nat Clin Prac Neurol, 2006, 2:
190–200.
Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine
and valproate monotherapy: Double-blind comparison
in newly diagnosed epilepsy. Acta Neurol Scand, 2003,
107:165–175.
Ptacek LJ, Fu YH. Channelopathies: Episodic disorders of the
nervous system. Epilepsia, 2001;42(suppl 5):35–43.
Quilichini PP, et al. Stiripentol, a putative antiepileptic drug,
enhances the duration of opening of GABA-A receptor channels.
Epilepsia 2006, 47:704–716.
Reid CA, Berkovic SF, Petrou S. Mechanisms of human inherited
epilepsies. Prog Neurobiol, 2008, Oct 5. (Epub ahead of
print.)
Rho JM, Donevan SD, Rogawski MA. Mechanism of action of
the anticonvulsant felbamate: Opposing effects on N-methyl-
D-aspartate and GABA A
receptors. Ann Neurol, 1994, 35:
229–234.
Rogawski MA, Bazil CW. New molecular targets for antiepileptic
drugs: 2
, SV2A, and K v
7/KCNQ/M potassium channels.
Curr Neurol Neurosci Rep, 2008, 8:345–352
Rogawski MA, Löscher W. The neurobiology of antiepileptic
drugs. Nat Rev Neurosci, 2004, 5:553–564,
Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized
trial of topiramate in Lennox-Gastaut syndrome:
Topiramate YL Study Group. Neurology, 1999, 52:1882–1887.
Sachdeo RC, Kramer LD, Rosenberg A, Sachdeo S. Felbamate
monotherapy: controlled trial in patients with partial onset
seizures. Ann Neurol, 1992, 32:386–392.
Sachdeo RC, Leroy RF, Krauss GL, et al. Tiagabine therapy for
complex partial seizures: A dose-frequency study. The
Tiagabine Study Group. Arch Neurol, 1997, 54:595–601.
Sivenius J, Kalviainen R, Ylinen A, et al. Double-blind study of
gabapentin in the treatment of partial seizures. Epilepsia, 1991,
32:539–542.
Steiner T J, Dellaportas CI, Findley LS, et al. Lamotrigine monotherapy
in newly diagnosed untreated epilepsy: A double-blind
comparison with phenytoin. Epilepsia, 1999, 40:601–607.
Traynelis SF, Dingledine R. Potassium-induced spontaneous
electrographic seizures in the rat hippocampal slice. J
Neurophysiol, 1988, 59:259–276.
Treiman DM, Meyers PD, Walton NY, et al. A comparison of
four treatments for generalized convulsive status epilepticus.
Veterans Affairs Status Epilepticus Cooperative Study Group.
N Engl J Med, 1998, 339:792–798.
Twyman RE, Rogers CJ, Macdonald RL. Differential regulation
of γ-aminobutyric acid receptor channels by diazepam and
phenobarbital. Ann Neurol, 1989, 25:213–220.
VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV.
Magnetic resonance imaging evidence of hippocampal injury
after prolonged focal febrile convulsions. Ann Neurol, 1998,
43:413–426.
Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized
epilepsy associated with a mutation in the Na + -channel
β1 subunit gene SCN1B. Nat Genet, 1998, 19:366–370.
Yu FH, et al. Reduced sodium current in GABAergic interneurons
in a mouse model of severe myoclonic epilepsy in
infancy. Nat Neurosci, 2006, 9:1142–1149.
Xie X, Lancaster B, Peakman T, Garthwaite J. Interaction of the
antiepileptic drug lamotrigine with recombinant rat brain type
IIA Na + channels and with native Na + channels in rat hippocampal
neurones. Pflugers Arch, 1995, 430:437–446.
607
CHAPTER 21
PHARMACOTHERAPY OF THE EPILEPSIES